The store will not work correctly when cookies are disabled.
US8796295, Table 2: Compound: 14
ID: ALA3694792
PubChem CID: 69937130
Max Phase: Preclinical
Molecular Formula: C16H12FN5O2
Molecular Weight: 325.30
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccnc(NC(=O)c2cc(F)cc(Oc3cncnc3)c2)n1
Standard InChI: InChI=1S/C16H12FN5O2/c1-10-2-3-20-16(21-10)22-15(23)11-4-12(17)6-13(5-11)24-14-7-18-9-19-8-14/h2-9H,1H3,(H,20,21,22,23)
Standard InChI Key: GCQMRMPNHPBXIY-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
2.3383 -1.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5972 -1.5031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5951 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5548 -3.6021 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8934 -5.2570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1924 -6.0071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1923 -7.2071 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-6.4914 -5.2571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4915 -3.7571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7897 -3.0041 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-7.7876 -1.5032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0841 -0.7487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0789 0.7513 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.7773 1.4968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4808 0.7424 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.4860 -0.7576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1925 -3.0071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
8 10 1 0
10 11 2 0
11 12 1 0
12 13 1 0
12 14 2 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
15 23 2 0
23 10 1 0
6 24 2 0
24 2 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 325.30 | Molecular Weight (Monoisotopic): 325.0975 | AlogP: 2.76 | #Rotatable Bonds: 4 |
Polar Surface Area: 89.89 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.05 | CX Basic pKa: 1.27 | CX LogP: 1.67 | CX LogD: 1.67 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.79 | Np Likeness Score: -1.84 |
References
1. (2014) Substituted benzamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same, |